2.10
Biofarmaceutisch onderzoek: Essentiële klinische studies
Biofarmaceutische studies vormen een vitaal veld dat gericht is op het verbeteren van medicijnafgiftemethoden en het verfijnen van therapeutische bena…
Biopharmaceutical studies aim to study drug delivery and improved therapies using interdisciplinary knowledge.
Non-controlled studies, often used for initial exploration, lack a control group, which can lead to biases and external influences.
Contrarily, controlled studies employ a control group and incorporate techniques such as placebo, historical, crossover, or standard treatment controls to reduce bias.
To further minimize bias, blinding keeps participants or investigators unaware of the assigned treatment. This includes single-blind, double-blind, and double-dummy studies.
Confounding, caused by external variables affecting the study's outcome, is mitigated through proper study design, methodology, and statistical analysis, and helps validate the study.
Internal validity addresses the quality of study execution, while external validity gauges the applicability of the findings to other populations.
In clinical studies, risk calculation estimates the exposure-outcome association. It encompasses measures like absolute and relative risks, absolute and relative risk reduction, treatment numbers, and hazards and odds ratio.
View the full transcript and gain access to JoVE Core videos
Q1: What is the main difference between controlled and non-controlled biopharmaceutical studies?
Non-controlled studies lack a control group, making them susceptible to biases and external influences, though useful for initial exploration. Controlled studies employ control groups and techniques such as placebo, historical, crossover, or standard treatment controls to reduce bias and validate findings more rigorously.
Q2: How does blinding reduce bias in biopharmaceutical research?
Blinding keeps participants or investigators unaware of assigned treatments, preventing biased observations. Single-blind designs hide treatment from participants only, double-blind designs hide it from both participants and investigators, and double-dummy designs use placebos for one treatment while administering the active form of another to maintain blinding across different treatment types.
Q3: What role do confounding variables play in study validity?
Confounding variables are external factors that can affect study outcomes and compromise reliability. Proper study design, meticulous methodology, and statistical analysis mitigate confounding effects. Addressing confounding is essential for establishing internal validity, which assesses the quality of study execution and the experimental design's impact on results.
Q4: How do internal and external validity differ in biopharmaceutical studies?
Internal validity assesses the quality of study execution and how well the experimental design controls for bias and confounding. External validity gauges whether study findings apply to broader populations and real-world scenarios, ensuring research outcomes hold relevance beyond the immediate study group.
Q5: What measures are used to calculate risk in clinical biopharmaceutical studies?
Risk calculation estimates the exposure-outcome association using measures like absolute and relative risks, absolute and relative risk reduction, treatment numbers, and hazard and odds ratios. These calculations quantify risks associated with specific interventions, providing insights into treatment benefits and drawbacks to guide clinical decisions.
Q6: Why is statistical analysis important for addressing confounding in biopharmaceutical research?
Statistical analysis helps validate study findings by identifying and controlling for confounding variables that could distort results. Advanced statistical methods work alongside proper study design and methodology to isolate the true effect of treatments, strengthening the reliability of conclusions drawn from biopharmaceutical studies.
Q7: What interdisciplinary knowledge supports biopharmaceutical study design?
Biopharmaceutical studies integrate diverse fields to enhance drug delivery methods and refine therapeutic approaches. This interdisciplinary foundation informs the selection of appropriate study designs, control mechanisms, blinding techniques, and statistical methods needed to produce reliable, valid research that advances pharmaceutical science and patient care.